LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success
ANDERNACH, Germany and MONTREAL, June 25, 2025 /CNW/ -- LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film (OTF) drug delivery technology, today announced a strategic collaboration to provide customers with robust, reliable, high-quality and cost-competitive large-scale manufacturing capacities. The collaboration leverages LTS's global expertise in technology transfer, scale-up, and manufacturing, providing Nualtis with resources to scale their innovative OTF products and deliver them to patients worldwide. Through this collaboration, the companies will jointly work towards delivering advanced OTF therapies that improve patient outcomes and address pressing healthcare challenges.
Nualtis has consistently demonstrated success in advancing OTF technologies. As Nualtis expands its pipeline of OTF programs, the collaboration supports scalable growth while offering its partners greater supply chain flexibility and security. The collaboration provides a unique opportunity for Nualtis to strengthen its position as a leader in the OTF market.
As global leader in the development and manufacturing of OTF LTS continues to strengthen its position as a platform specialist by leveraging deep expertise to deliver exceptional outcomes for partners and their patients. Committed to innovation and long-term growth, LTS is actively investing in the future through collaboration with other organizations, advanced R&D resources, and expanded manufacturing capacity. These efforts ensure LTS remains at the forefront of oral thin film technology, driving progress across the healthcare landscape.
"Teaming up Nualtis' excellent OTF Formulation platform with LTS's world-class manufacturing capabilities, allows the two companies to accelerate our shared vision of bringing patient-centric therapeutical solutions to our pharma partners." said Bas van Buijtenen, CEO of LTS. "It provides LTS with an exciting opportunity to extend the reach of our mission of "We CARE, We CREATE, We DELIVER" to a wider range of molecules and therapies."
"Nualtis is entering a new phase of growth, and this collaboration ensures we are ready," said Dr. Michael Raven, CEO of Nualtis. "Working with LTS allows us to complement our in-house manufacturing capabilities - giving our partners the confidence that we can support them from early development through to full-scale commercialization."
Together, Nualtis and LTS will jointly support customers through every phase of drug development and commercialization by combining innovation with proven execution. The companies remain aligned in their commitment to delivering high-quality, reliable, and scalable OTF solutions that improve treatment outcomes across a broad range of indications.
About LTS Lohmann Therapie-Systeme AG
We CARE. We CREATE. We DELIVER. The driving philosophy behind LTS. As a trusted technology partner for the pharmaceutical industry, we develop and manufacture innovative drug delivery systems such as Transdermal Patches ("TTS") and Oral Thin Films ("OTF") as well as wearable drug delivery devices ("OBDS"). LTS´ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 40 development projects targeting multiple disease indications. LTS's innovation pipeline contains both partner-funded as well as proprietary, LTS-funded projects. LTS maintains its leading position through the continuous refinement of its core TTS and OTF technologies and by advancing emerging drug delivery technologies, including Microneedle Array Patches ("MAP") for the transdermal delivery of small and large molecules, biological actives and vaccines. With its SorrelTM wearable drug delivery platform LTS offers patient friendly solutions for complex drugs delivery at home. Founded in 1984, LTS operates today from four sites: in Andernach, Germany, West Caldwell, NJ, USA, St. Paul, MN, USA and Netanya, Israel. LTS has also a representative office in Shanghai, China.
About Nualtis
Nualtis is a specialty pharmaceutical company advancing innovative drug delivery technologies with a focus on oral thin film (OTF) pharmaceutical products. Nualtis' superior film technologies, including VersaFilm®, DisinteQ™, VetaFilm® and transdermal VevaDerm™, allow for next generation pharmaceutical products that address unmet medical needs. Nualtis' innovative product pipeline offers significant benefits to patients and physicians for many therapeutic conditions. Building on more than a decade of formulation and manufacturing expertise, Nualtis supports pharmaceutical partners in extending product lifecycles and accelerating development timelines. Headquartered in Montreal, the company offers a fully integrated platform that includes research and development, analytical services, regulatory support, and scalable manufacturing from lab to market. With a patient centered approach and a focus on execution excellence, Nualtis delivers smart solutions that meet real world therapeutic needs. Nualtis is a wholly owned subsidiary of atai Life Sciences. For more information, visit www.nualtis.com or connect with us on LinkedIn and X.
For further information, please contact:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
34 minutes ago
- Cision Canada
Canadian Airports Celebrate Second Annual Airport Workers Day with Expanded National Awards Honouring Excellence Across the Sector Français
OTTAWA, ON, June 25, 2025 /CNW/ - Today, over 30 airports across Canada will come together to celebrate the second annual Airport Workers Day, a national event recognizing the contributions of the people who keep Canada's aviation system running. From front-line agents to behind-the-scenes technicians, this day honours the individuals who connect people and goods, communities, and Canada to the world. This year, the Canadian Airports Council (CAC) is proud to expand the celebration by presenting eight national awards to outstanding airport workers across the country. This year's award recipients are: Jocelyn Alexander, Calgary International Airport – Rising Star Mike Lazenby, Dexterra Group, Edmonton International Airport – Excellence in Efficiency Optimization Zaina Alhillou, Qafiya Consulting Inc., PortsToronto – Airport Innovator Roger Hussey, Inland Technologies, St. John's International Airport – Environmental Steward Water Fasan, Toronto-Pearson – Outstanding Service Karen Funk, Victoria Airport Authority – Operational Excellence Lahcen Bouachra, Alstef Canada Inc., Montréal-Trudeau International Airport – Outstanding Leadership Vivian Chan, Vancouver International Airport – Industry Champion "This day is about recognizing the dedication and importance of airport workers across the country," said Monette Pasher, President of the Canadian Airports Council. "With more than 200,000 people working directly in airports, supporting passenger and cargo operations, and 150 million passengers expected to travel through Canada's airports in 2025, it is important we take a moment to thank the teams who make it all possible." Canada's airports are more than travel hubs, they are vital infrastructure that powers the economy. Nationally, airports support 435,800 jobs, provide $32.9 billion in annual wages, generate $49.6 billion in GDP, and produce $123.5 billion in total annual economic output. Across the country, participating airports will host appreciation events for their teams who keep the engine of Canada's aviation industry moving. These celebrations are a small way to thank the teams whose work is essential to the safety, efficiency, and success of Canada's air transportation system. From equipment operators and customer service agents to security personnel, mechanics, and firefighters, the wide range of roles at airports reflects the diversity and depth of talent in the industry. Airport Workers Day is a coordinated national effort to celebrate our workforce and highlight the vital role aviation plays in our economy and communities. Join the celebration and share your appreciation using #AirportWorkersDay2025. About the Canadian Airports Council The Canadian Airports Council (CAC), a division of Airports Council International-North America, is the voice for Canada's airports community. Its 60 members represent more than 100 airports, including all of the privately-operated National Airports System (NAS) airports and many municipal airports across Canada.
Cision Canada
an hour ago
- Cision Canada
CIRO Releases 2025 Enforcement Report Français
TORONTO, /CNW/ - Today, the Canadian Investment Regulatory Organization (CIRO) released its annual Enforcement Report highlighting the previous year's enforcement activities which include complaint intake, investigations and proceedings against dealers and approved persons who have contravened CIRO regulations. Enforcement is a key lever in deterring potential harmful conduct and sending strong regulatory messages to the industry. The report aims to bring transparency to CIRO's Enforcement actions by gathering together all CIRO proceedings from the previous year and showcasing the contraventions involved and the sanctions that were imposed. The report also showcases case highlights and key statistics about the activities of the Enforcement department and the kinds of complaints, investigations and cases CIRO has encountered in the past year. It provides visualization of the trends in regulatory violations, complaint sources, and the pan-Canadian coverage of both investigations and proceedings. "In the 2025 fiscal year, Enforcement identified and pursued cases with significant deterrent impact and sent a strong regulatory message to the industry about the consequences for violating regulations," said Alexandra Williams, Senior Vice-President, Strategy, Innovation and Stakeholder Protection. "The team continues to harmonize and create efficiencies that will help us tackle financial crimes, wrongdoing and increased complaints and inquiries." Since its founding, CIRO has been committed to regulatory evolution and harmonization. Highlights from the 2024-2025 Enforcement Report: Reviewed 4,127 complaints received from sources including the public, whistleblowers, ComSet/METS, commissions and other regulators, and internal CIRO departments such as Surveillance, Compliance and Member Registration. Conducted 176 investigations with 34% referred for prosecution. Completed 57 enforcement proceedings. Imposed $10,313,381 in fines, costs and disgorgement. Significant achievements in the past year also include transforming the event reporting system used by mutual fund dealers to ComSet. Enforcement transitioned to a single document management system and a single case management system, harmonizing legacy interfaces. The team launched a new E-Discovery and Evidence team, increasing the capabilities and resources of the Enforcement department.
Cision Canada
2 hours ago
- Cision Canada
OSC provides 3-year funding to Prosper Canada
TORONTO, June 25, 2025 /CNW/ - The Ontario Securities Commission (OSC) is announcing it will provide multi-year funding of up to $5.4-million to Prosper Canada to support projects that provide investor education, as well as to strengthen financial coaching services. is a national charity dedicated to expanding economic opportunity for Canadians living in poverty through program and policy innovation. "Prosper Canada champions financial literacy and empowerment through education, research and outreach," said Grant Vingoe, OSC CEO. "By providing funding to Prosper Canada, we are investing in Ontarians and ensuring they have access to the resources and support to navigate the complexities of the financial landscape." The $5.4-million funding will be allocated over a period of three years. The funding will be used by Prosper Canada to support the provision of tailored financial education and counselling to Ontarians living on low and moderate incomes, and to work with Indigenous community partner organizations to develop tailored financial resources and support that meets the unique needs of Indigenous community members. The mandate of the OSC is to provide protection to investors from unfair, improper or fraudulent practices, to foster fair, efficient and competitive capital markets and confidence in the capital markets, to foster capital formation, and to contribute to the stability of the financial system and the reduction of systemic risk. Investors are urged to check the registration of any persons or company offering an investment opportunity and to review the OSC investor materials available at
